Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lewis R Roberts

Showing results (291-300 of 394) with videos related to

Pageof 40
Sort By:
Cancer|August 23, 2022
Disparities in curative treatments and outcomes for early stage intrahepatic cholangiocarcinoma in the United StatesYi-Te Lee, Amit G Singal, Marie Lauzon, et al.
Clinical and Translational Medicine|June 20, 2023
Loss of LncRNA DUXAP8 synergistically enhanced sorafenib induced ferroptosis in hepatocellular carcinoma via SLC7A11 de-palmitoylationZhehao Shi, Zhiming Li, Bin Jin, et al.
The American Journal of Tropical Medicine and Hygiene|February 22, 2021
Distribution and Incidence of Blood-Borne Infection among Blood Donors from Regional Transfusion Centers in Burkina Faso: A Comprehensive StudyNicha Wongjarupong, Sharad Oli, Mahamoudou Sanou, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 19, 2017
More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinomaTomi W Jun, Ming-Lun Yeh, Ju Dong Yang, et al.
The Journal of Clinical Investigation|January 14, 2021
Apobec1 complementation factor overexpression promotes hepatic steatosis, fibrosis, and hepatocellular cancerValerie Blanc, Jesse D Riordan, Saeed Soleymanjahi, et al.
Gastroenterology|April 14, 2009
Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinomaJorge A Marrero, Ziding Feng, Yinghui Wang, et al.
The Journal of Clinical Investigation|June 2, 2025
Apobec1 complementation factor overexpression promotes hepatic steatosis, fibrosis, and hepatocellular cancerValerie Blanc, Jesse D Riordan, Saeed Soleymanjahi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 5, 2017
Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine TransaminaseJu Dong Yang, Jianliang Dai, Amit G Singal, et al.
The American Journal of Gastroenterology|May 15, 2008
Prospective evaluation of advanced molecular markers and imaging techniques in patients with indeterminate bile duct stricturesMichael J Levy, Todd H Baron, Amy C Clayton, et al.
Cancer Research Communications|September 26, 2024
GALAD Score for the Diagnosis of Hepatocellular Carcinoma in Sub-Saharan Africa: A Validation Study in Ghanaian PatientsYvonne Ayerki Nartey, Ju Dong Yang, Tyler J Zemla, et al.
Pageof 40

Showing results (291-300 of 394) with videos related to

Sort By:
Pageof 40
Cancer|August 23, 2022
Disparities in curative treatments and outcomes for early stage intrahepatic cholangiocarcinoma in the United StatesYi-Te Lee, Amit G Singal, Marie Lauzon, et al.
Clinical and Translational Medicine|June 20, 2023
Loss of LncRNA DUXAP8 synergistically enhanced sorafenib induced ferroptosis in hepatocellular carcinoma via SLC7A11 de-palmitoylationZhehao Shi, Zhiming Li, Bin Jin, et al.
The American Journal of Tropical Medicine and Hygiene|February 22, 2021
Distribution and Incidence of Blood-Borne Infection among Blood Donors from Regional Transfusion Centers in Burkina Faso: A Comprehensive StudyNicha Wongjarupong, Sharad Oli, Mahamoudou Sanou, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 19, 2017
More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinomaTomi W Jun, Ming-Lun Yeh, Ju Dong Yang, et al.
The Journal of Clinical Investigation|January 14, 2021
Apobec1 complementation factor overexpression promotes hepatic steatosis, fibrosis, and hepatocellular cancerValerie Blanc, Jesse D Riordan, Saeed Soleymanjahi, et al.
Gastroenterology|April 14, 2009
Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinomaJorge A Marrero, Ziding Feng, Yinghui Wang, et al.
The Journal of Clinical Investigation|June 2, 2025
Apobec1 complementation factor overexpression promotes hepatic steatosis, fibrosis, and hepatocellular cancerValerie Blanc, Jesse D Riordan, Saeed Soleymanjahi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 5, 2017
Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine TransaminaseJu Dong Yang, Jianliang Dai, Amit G Singal, et al.
The American Journal of Gastroenterology|May 15, 2008
Prospective evaluation of advanced molecular markers and imaging techniques in patients with indeterminate bile duct stricturesMichael J Levy, Todd H Baron, Amy C Clayton, et al.
Cancer Research Communications|September 26, 2024
GALAD Score for the Diagnosis of Hepatocellular Carcinoma in Sub-Saharan Africa: A Validation Study in Ghanaian PatientsYvonne Ayerki Nartey, Ju Dong Yang, Tyler J Zemla, et al.
Pageof 40